Wave Life Sciences (WVE) EBT Margin (2015 - 2026)
Wave Life Sciences (WVE) posted EBT Margin of 68.21% for Q1 2026, up 88.24% on a QoQ basis from 580.17% in Q2 2025, and up 44272.0% year-over-year from N/an in Q1 2025.
Wave Life Sciences (WVE) EBT Margin (2015 - 2026) Analysis & Trends
Wave Life Sciences' EBT Margin history runs 12 years deep, the most recent figure standing at 68.21% for Q1 2026.
- Quarterly EBT Margin rose 44272.0% year-over-year to 68.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 242.16% (down 8274.0% YoY) and the FY2025 annual result came in at 478.33%, down 38876.0% from the prior year.
- EBT Margin was 68.21% for Q1 2026 at Wave Life Sciences, up from 580.17% in the prior quarter.
- Across five years, EBT Margin topped out at 13.36% in Q3 2023 and bottomed at 13685.61% in Q3 2022.
- A 5-year average of 2481.52% and a median of 251.7% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 1366851 bps — and 2023, when it surged 1369897 bps.
- Wave Life Sciences' EBT Margin stood at 3472.8% in 2022, then soared by 98 bps to 55.95% in 2023, then plunged by 199 bps to 167.19% in 2024, then tumbled by 247 bps to 580.17% in 2025, then soared by 88 bps to 68.21% in 2026.
- Business Quant data shows WVE's EBT Margin at 68.21% in Q1 2026, 580.17% in Q2 2025, and 510.93% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -68.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.21% |
| Jun 30, 2025 | -580.17% |
| Mar 31, 2025 | -510.93% |
| Jun 30, 2024 | -167.19% |
| Mar 31, 2024 | -251.70% |
| Dec 31, 2023 | -55.95% |
| Sep 30, 2023 | 13.36% |
| Jun 30, 2023 | -95.47% |
| Mar 31, 2023 | -211.97% |
| Dec 31, 2022 | -3,472.80% |
| Sep 30, 2022 | -13,685.61% |
| Jun 30, 2022 | -11,012.27% |
| Mar 31, 2022 | -2,160.80% |
| Dec 31, 2021 | -1,982.38% |
| Sep 30, 2021 | -17.10% |
| Jun 30, 2021 | -1,396.47% |
| Dec 31, 2020 | -313.91% |
| Sep 30, 2020 | -959.42% |
| Jun 30, 2020 | -1,338.88% |
| Mar 31, 2020 | -1,141.38% |